Alastair Thompson, MD, MBChB, Professor and Chief, Section of Breast Surgery, Baylor College of Medicine comments: “The collaboration with ARTIDIS is an exciting opportunity to bring novel technology to patient care and, together with TMC, place ARTIDIS in the front line of implementing innovative solutions to clinical problems, starting with breast cancer.”
Vittorio Cristini, PhD, Director, Mathematics in Medicine Program, Houston Methodist Research Institute, and scientific collaborator of ARTIDIS adds: “The integration of ARTIDIS technology with the mechanistic mathematical models that I have developed with my team will allow us to revolutionize individualized treatment optimization for cancer patients. This technology powerhouse, combined with the extensive availability of real patient data that we have through our collaborators here at the TMC, is the formula that will enable us to impact cancer care in the upcoming years in potentially unprecedented ways. This is an exciting place and time to be at, in leading medicine.”
Lance Black, MD, MBID, Associate director at TMCx comments: “Prior to joining TMCx, ARTIDIS established collaborations with leading clinical researchers at multiple TMC Member Institutions. The TMC Innovation team is dedicated to providing additional resources and infrastructure to ARTIDIS so that they may capitalize on these relationships. TMC Innovation is excited to support ARTIDIS’ US clinical studies as they prepare for US market entry. Marija Plodinec and her team have already proven to be an excellent addition to our TMC Innovation community, and we look forward to their positive impact on healthcare.”
Anil Shetty, MD, Advisor to TMCx added: “The ARTIDIS platform and software will expedite biopsy based tumor diagnosis with their unique nanomechanical biomarker, enhance treatment decision making and drop healthcare costs by preventing unnecessary treatments. It has a great future in non-oncology applications too.”
About TMC Innovation
Texas Medical Center (TMC) — the largest medical city in the world — is at the forefront of advancing life sciences. Home to the brightest minds in medicine, TMC nurtures cross-institutional collaboration, creativity and innovation among its 106,000-plus employees. With a campus of more than 50 million square feet, TMC annually hosts 10 million patients, performs over 180,000 surgeries, conducts over 750,000 ER visits, performs close to 14,000 heart surgeries and delivers over 25,000 babies. Beyond patient care, TMC is pushing the boundaries of clinical research across its extensive network of partner institutions on a daily basis, pioneering effective health policy solutions to address the complex health care issues of today and cultivating cutting-edge digital health applications and medical devices.
